Merck chief casts doubt on coronavirus vaccine timeframe
Ken Frazier calls 12 to 18-month targets ‘very aggressive’ as he announces biotech acquisition
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Coronavirus | COVID-19 | Merck | Mergers and Aquisitions | Pharmaceuticals | Vaccines